Johnson & Johnson’s $6.5 Billion Settlement to Resolve ‘Talc Ovarian Cancer Lawsuits’ Shakes Up Healthcare Industry
In a significant development that could redefine corporate accountability and consumer safety in the healthcare sector, Johnson & Johnson has ...